Triple Antibiotic Gel in The Management of Periodontal Disease: A Narrative Review
- 1. International Journal of Dental Science and Innovative Research (IJDSIR)
Description
Abstract
Periodontal disease is a chronic inflammatory condition caused by bacterial biofilms, leading to progressive destruction of the tooth-supporting structures. Conventional treatments such as scaling and root planing (SRP) are effective but may not completely eradicate pathogenic bacteria, necessitating adjunctive antimicrobial therapies. The use of locally delivered antibiotic gels has emerged as a promising approach to enhance periodontal healing. Triple antibiotic gel formulations, commonly consisting of metronidazole, ciprofloxacin, and minocycline, offer targeted antimicrobial action, reducing bacterial load and inflammation within periodontal pockets. Localized drug delivery minimizes systemic side effects while maintaining therapeutic concentrations at the site of infection. Despite these benefits, concerns remain regarding antibiotic resistance, potential allergic reactions, and long-term efficacy. This review discusses the role of triple antibiotic gel in periodontal therapy, its clinical effectiveness, advantages, limitations, and future research directions. Optimizing antibiotic formulations and developing strategies to mitigate resistance will be essential for ensuring the long-term success of this therapeutic approach in periodontal disease management.
Files
CHAITANYA.pdf
Files
(718.4 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:f8beee79fd5cbc78340d9e95a1277f21
|
718.4 kB | Preview Download |
Additional details
Software
References
- 1. Page RC. The etiology and pathogenesis of periodontitis. Compend Contin Educ Dent 2002; 2311-14. 2. Bartold PM, Van Dyke TE. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000. 2013 Jun;62(1):203-17. 3. Heitz-Mayfield LJ, Lang NP. Surgical and nonsurgical periodontal therapy. Learned and unlearned concepts. Periodontol 2000 2013;62:218-31. 4. Serrano C, Torres N, Valdivieso C, Casta~no C, Barrera M, Cabrales A. Antibiotic resistance of periodontal pathogens obtained from frequent antibiotic users. Acta Odontol Latinoam 2009: 22: 99–104. 5. Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontol 2000. 2016;71:82-112. 6. Dabhi MR, Sheth NR. Formulation development of physiological environment responsive periodontal drug delivery system for local delivery of metronidazole benzoate. Drug Dev Ind Pharm. 2013; 39:425-436. 7. Greenstein G, Tonetti M. The role of controlled drug delivery for periodontitis. The Research, Science and Therapy Committee of the American Academy of Periodontology. J Periodontol.2000;71:125-140. 8. Goodson JM, Haffajee A, Socransky SS. Periodontal therapy by local delivery of tetracycline. J Clin Periodontol. 1979;6:83-92. 9. Zieba M, Chaber P, Duale K, et al. Polymeric carriers for delivery systems in the treatment of chronic periodontal disease. Polymers (Basel). 2020;12:1574. 10. Greenstein G, Tonetti M. The role of controlled drug delivery for periodontitis. J Periodontol. 2000;71: 125-140. 11. Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontol 2000. 2016;71(1):82-112. 12. Mohamed Haris PM, Panickal DM. Role of Metronidazole as a Local Drug Delivery in the Treatment of Periodontitis:A Review. Int J Oral Health Med Res 2017;3(6):141-5 13. Jain R, Mohamed F, Hemalatha M. Minocycline containing local drug delivery system in the management of chronic periodontitis: a randomized controlled trial. J Indian Soc Periodontol. 2012; 16(2):179-183. 14. Kapoor A, Malhotra R, Grover V, Grover D. Systemic antibiotic therapy in periodontics. Dent Res J (Isfahan). 2012;9(5):505-515.